Commonwealth Equity Services’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$80K Buy
148,314
+50,000
+51% +$27K ﹤0.01% 4099
2025
Q1
$64K Buy
98,314
+2,813
+3% +$1.83K ﹤0.01% 4043
2024
Q4
$97K Buy
95,501
+27,353
+40% +$27.8K ﹤0.01% 3911
2024
Q3
$59K Buy
68,148
+8,400
+14% +$7.27K ﹤0.01% 3916
2024
Q2
$21K Sell
59,748
-204
-0.3% -$72 ﹤0.01% 3968
2024
Q1
$40K Buy
59,952
+28,304
+89% +$18.9K ﹤0.01% 3916
2023
Q4
$17K Sell
31,648
-18,648
-37% -$10K ﹤0.01% 3829
2023
Q3
$30K Buy
50,296
+4,436
+10% +$2.65K ﹤0.01% 3705
2023
Q2
$60K Buy
45,860
+18,895
+70% +$24.7K ﹤0.01% 3641
2023
Q1
$47 Buy
26,965
+387
+1% +$1 ﹤0.01% 3588
2022
Q4
$83K Buy
26,578
+2,754
+12% +$8.6K ﹤0.01% 3445
2022
Q3
$116K Hold
23,824
﹤0.01% 3339
2022
Q2
$98K Buy
23,824
+818
+4% +$3.37K ﹤0.01% 3379
2022
Q1
$133K Sell
23,006
-8,814
-28% -$51K ﹤0.01% 3430
2021
Q4
$238K Sell
31,820
-1,218
-4% -$9.11K ﹤0.01% 3157
2021
Q3
$297K Sell
33,038
-2,391
-7% -$21.5K ﹤0.01% 2950
2021
Q2
$424K Sell
35,429
-1,100
-3% -$13.2K ﹤0.01% 2597
2021
Q1
$457K Buy
36,529
+15,514
+74% +$194K ﹤0.01% 2403
2020
Q4
$327K Sell
21,015
-1,312
-6% -$20.4K ﹤0.01% 2498
2020
Q3
$210K Sell
22,327
-1,000
-4% -$9.41K ﹤0.01% 2679
2020
Q2
$209K Buy
23,327
+6,687
+40% +$59.9K ﹤0.01% 2558
2020
Q1
$106K Sell
16,640
-9,672
-37% -$61.6K ﹤0.01% 2567
2019
Q4
$220K Buy
26,312
+11,119
+73% +$93K ﹤0.01% 2545
2019
Q3
$137K Buy
15,193
+678
+5% +$6.11K ﹤0.01% 2630
2019
Q2
$156K Sell
14,515
-1,081
-7% -$11.6K ﹤0.01% 2574
2019
Q1
$148K Sell
15,596
-11,824
-43% -$112K ﹤0.01% 2534
2018
Q4
$314K Sell
27,420
-398
-1% -$4.56K ﹤0.01% 1979
2018
Q3
$471K Buy
27,818
+10,185
+58% +$172K ﹤0.01% 1821
2018
Q2
$250K Buy
17,633
+2,447
+16% +$34.7K ﹤0.01% 2285
2018
Q1
$288K Buy
+15,186
New +$288K ﹤0.01% 2090
2017
Q4
Sell
-11,193
Closed -$168K 2714
2017
Q3
$168K Hold
11,193
﹤0.01% 2337
2017
Q2
$99K Buy
+11,193
New +$99K ﹤0.01% 2375